The Global Hematopoietic Stem Cells Transplantation Market has been projected to grow at the CAGR of 10.4% market during 2017-2025. In 2016, the market has generated the revenue of $ 4,121.6 million and now it has been expected to reach up to $ 10,754.7 million in terms of revenue by 2025.
Researchers have developed tremendous understanding to use HSCs as a treatment therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Through animal studies researchers have observed that HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.
Market Segment Insights
The hematopoietic stem cells transplantation market is majorly segmented into application such as (leukemia, lymphoproliferative disorders, solid tumors, and non-malignant disorders). The leukemia and lymphoproliferative disorders held the largest market in the applications segment chiefly due to factors like increasing number of cancer patients, and blood disorders. The transplant type segment consists of (allogeneic transplant, and autologous transplant), the autologous HSCT held the largest market due to factors such as absence of risk of graft versus host disease.
North America, Latin America, Europe, Middle East and Africa and Asia Pacific, markets together form the major regional markets for hematopoietic stem cells transplantation market. These regional markets are further sub-segmented into country specific markets on the basis of demand and market growth of hematopoietic stem cells transplantation market. Among the considered regional markets, North America currently dominates the global hematopoietic stem cells transplantation market, with United Sates being the largest county-level market. Increase in number of patients suffering with blood disorders, rising public awareness, and supportive reimbursement policies. On the other hand, Asia-Pacific is anticipated to be the fastest growing market for due huge population base suffering with blood cancer, medical tourism and advanced healthcare infrastructure.
Market Competition Assessment:
Key players in the global hematopoietic stem cells transplantation market are: CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., Genlantis, Kite Pharma Inc., Lonza Group Ltd., Pluristem Therapeutics Inc., PromoCell GmbH, R&D Systems, ScienCell research laboratories, Stempuetics Research Pvt. Ltd., Takara Bio, Thermo Fisher Scientific, TiGenix N.V.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Hematopoietic Stem Cell Transplantation Market, by Transplantation Type, 2016($ Million)
2.2 Global Hematopoietic Stem Cell Transplantation Market, by Application Type, 2016 ($ Million)
2.3 Global Hematopoietic Stem Cell Transplantation Market, by Geography, 2016 (Value %)
Chapter 3 Global Hematopoietic Stem Cells Transplantation Market Overview
3.2 Market Drivers
3.2.1 Increasing Prevalence of Blood Cancer
3.2.2 Better Survival Rates
3.3 Market Restraints
3.3.1 Technical Challenges for Engineering Synthetic HSC Niches at the Nano scale
3.3.2 Infectious Complications of Hematopoietic Stem Cell Transplantation
3.4 Market Opportunities
3.4.1 Future in Regenerative Stromal Cell Therapy
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Hematopoietic Stem Cells Transplantation Market, by Key Players
Chapter 4 Global Hematopoietic Stem Cells Transplantation Market Analysis, By Transplant Type, 2015-2025 ($ Million)
4.2 Autologous Transplant
4.3 Allogeneic Transplant
Chapter 5 Global Hematopoietic Stem Cells Transplantation Market Analysis, By Applications, 2015-2025 ($ Million)
5.3 Lymphoproliferative Disorders
5.4 Solid Tumors
5.5 Non-malignant Disorders
Chapter 6 Global Hematopoietic Stem Cells Market, by Geography, 2015-2025 ($ Million)
6.1. North America
6.2.3. Rest of Europe
6.3. Asia Pacific
6.3.3. Rest of Asia Pacific
6.4. Latin America
6.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.2. Rest of Middle East and Africa
Chapter 7 Company Profiles
7.1. CellGenix Technologie Transfer GmbH
7.2. Cesca Therapeutics Inc.
7.3. Escape Therapeutics
7.5. Kite Pharma Inc.
7.6. Lonza Group
7.7. PromoCell GmbH
7.8. Pluristem Therapeutics Inc.
7.9. R&D Systems
7.10. ScienCell Research Laboratories
7.11. Stempuetics Research Pvt. Ltd.
7.12. Takara Bio
7.13. Thermo Fisher Scientific, Inc.
7.14. TiGenix N.V.